Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 27, 2022

SELL
$325.8 - $407.78 $5,212 - $6,524
-16 Reduced 84.21%
3 $1,000
Q2 2022

Aug 09, 2022

SELL
$327.37 - $553.44 $327 - $553
-1 Reduced 5.0%
19 $7,000
Q1 2022

May 18, 2022

SELL
$466.52 - $631.01 $1,399 - $1,893
-3 Reduced 13.04%
20 $11,000
Q3 2021

Oct 14, 2021

SELL
$621.9 - $705.76 $4,353 - $4,940
-7 Reduced 23.33%
23 $14,000
Q3 2020

Nov 18, 2020

SELL
$334.54 - $406.31 $1.7 Million - $2.07 Million
-5,096 Reduced 99.41%
30 $12,000
Q2 2020

Aug 14, 2020

BUY
$230.66 - $330.16 $1.17 Million - $1.68 Million
5,088 Added 13389.47%
5,126 $1.69 Million
Q1 2020

May 04, 2020

SELL
$182.94 - $290.97 $365 - $581
-2 Reduced 5.0%
38 $9,000
Q1 2019

May 14, 2019

SELL
$178.02 - $225.69 $6,408 - $8,124
-36 Reduced 47.37%
40 $9,000
Q1 2018

Apr 30, 2018

BUY
$157.81 - $204.73 $11,993 - $15,559
76 New
76 $15,000

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $35.6B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Financial Enhancement Group LLC Portfolio

Follow Financial Enhancement Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Enhancement Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Enhancement Group LLC with notifications on news.